Recent News

• 04.27.2025 - AACR Annual Meeting 2025
• 03.25.2025 - Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
• 12.12.2024 - Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing
• 12.12.2024 - Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Recent Filings

• 03.26.2025 - 8-K Current report
• 03.26.2025 - EX-99.1 EX-99.1
• 03.24.2025 - DEF 14A Other definitive proxy statements
• 03.13.2025 - PRE 14A Other preliminary proxy statements
• 03.07.2025 - 8-K Current report
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report
• 02.21.2025 - EX-99.1 EX-99.1
• 02.21.2025 - 8-K Current report
• 02.12.2025 - EFFECT Notice of Effectiveness